As shown in Figure 5, these key targets were highly correlated in the potential target network relationship of compound Xuanju capsule-treated RA, including IL-6, VEGFA, TNF, AKT1, MAPK3, CXCL8, IL10, IL1β, JUN and CASP3. This evidence concerns the gene MAPK3 and rheumatoid arthritis.